title: Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma.
authors.forename: Erhan
authors.initials: E
authors.lastname: Ararat
authors.forename: Ilyas
authors.initials: I
authors.lastname: Sahin
authors.forename: Evren
authors.initials: E
authors.lastname: Ozdemir
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000188:drug therapy*; D000077211:Zoledronic Acid
chemical_list: D000970:Antineoplastic Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid